DataMEDS AI, Inc. (MEDS) Financial Ratios
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
MEDS stock: frequently asked questions
What is MEDS's ST Score?
DataMEDS AI, Inc. (MEDS) has an ST Score of 33.6 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MEDS a buy, hold, or sell?
Our ST Score grades it C- (33.6/100). The ST Score is a data-driven signal, not a recommendation.
What are MEDS's factor grades?
Valuation B, Profitability C-, Financial Strength C-, Momentum B+, Growth F.
What is MEDS's valuation grade?
DataMEDS AI, Inc. (MEDS) earns a valuation grade of B, measured against Medical - Distribution peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MEDS's growth grade?
DataMEDS AI, Inc. (MEDS) earns a growth grade of F, measured against Medical - Distribution peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MEDS's profitability grade?
DataMEDS AI, Inc. (MEDS) earns a profitability grade of C-, measured against Medical - Distribution peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MEDS's financial strength grade?
DataMEDS AI, Inc. (MEDS) earns a financial strength grade of C-, measured against Medical - Distribution peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is MEDS's Piotroski score?
DataMEDS AI, Inc. (MEDS) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.